We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Victim Impact Modules for Jail Inmates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01381146
Recruitment Status : Withdrawn (Results from Phase II Study did not support "dismantling")
First Posted : June 27, 2011
Last Update Posted : April 25, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to evaluate feasibility of modularized delivery of the Impact of Crime (IOC) group intervention with jail inmates, and obtain preliminary data on its effectiveness in reducing post-release recidivism, substance abuse, and HIV risk behavior.

Condition or disease Intervention/treatment
Substance Abuse HIV Risk Shame Guilt Empathy Criminogenic Thinking Behavioral: Impact of Crime Modules Behavioral: TAU

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Phase 1-2 Study of Victim Impact Group Modules for Jail Inmates
Actual Study Start Date : July 15, 2016
Primary Completion Date : July 15, 2016
Study Completion Date : July 15, 2016
Arms and Interventions

Arm Intervention/treatment
Experimental: Impact of Crime Modules
5 session/1 week modules of a restorative justice inspired victim impact group intervention
Behavioral: Impact of Crime Modules
5 session/1 week modules of a restorative justice inspired victim impact group intervention
TAU
treatment as usual -- participants have access to all other jail programs and services
Behavioral: TAU
have access to other jail programs and services


Outcome Measures

Primary Outcome Measures :
  1. Recidivism - Self report of arrests and undetected crimes [ Time Frame: 3 months post-release up to 9 mos ]
  2. Acceptability - number of participants who indicate the module was helpful and number who would recommend treatment to a friend [ Time Frame: 1 week post-treatment up to 2 weeks ]
  3. Number of inmates who complete the intervention [ Time Frame: 5 sessions over a period of 1 week ]

Secondary Outcome Measures :
  1. Self reported Substance use and dependence -Texas Christian University measure [ Time Frame: 3 months post-release up to 9 mos ]
  2. Self reported HIV risk behavior (sex and Intravenous Drug Use) Texas Christian University measure [ Time Frame: 3 months post-release up to 9 mos ]
  3. Changes in self-reported Shame-proneness from baseline [ Time Frame: Changes from pre- to post-treatment up to 12 weeks ]
  4. Changes in self-reported Shame-proneness from baseline [ Time Frame: Changes from pre-treatment to 3 mos post-release up to 9 mos ]
  5. Changes in self-reported Guilt-proneness from baseline [ Time Frame: Changes from pretreatment to 3 months post-release up to 9 mos ]
  6. Changes in self-reported Guilt-proneness from baseline [ Time Frame: Changes from pretreatment to post-treatment up to 12 weeks ]
  7. Changes in self-reported empathy from baseline [ Time Frame: changes from pre- to post-treatment up to 12 weeks ]
  8. Changes in self-reported empathy from baseline [ Time Frame: changes from pre-treatment to 3 mos post-release up to 9 mos ]
  9. Changes in self reported criminogenic thinking from baseline [ Time Frame: changes from pre-treatment to post-treatment up to 12 weeks ]
  10. Changes in self reported criminogenic thinking from baseline [ Time Frame: changes from pre-treatment to 3 mos post-release up to 9 mos ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Sentence must be short enough to serve out sentence at ADC
  • Release date must follow projected final session of treatment
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01381146


Locations
United States, Virginia
Fairfax County Adult Detention Center
Fairfax, Virginia, United States, 22030
Sponsors and Collaborators
George Mason University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: June P Tangney, Ph.D. George Mason University
More Information

Responsible Party: June Tangney, Professor, George Mason University
ClinicalTrials.gov Identifier: NCT01381146     History of Changes
Other Study ID Numbers: R01DA014694-12 ( U.S. NIH Grant/Contract )
R01DA014694 ( U.S. NIH Grant/Contract )
First Posted: June 27, 2011    Key Record Dates
Last Update Posted: April 25, 2017
Last Verified: April 2017

Keywords provided by June Tangney, George Mason University:
criminal behavior
substance abuse
HIV risk behavior
criminogenic thinking
shame
guilt
empathy
jail inmates
restorative justice
Crime

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders